Attached files

file filename
EX-10.1 - EX-10.1 - BLUE CALYPSO, INC.ex10-1.htm
EX-10.2 - EX-10.2 - BLUE CALYPSO, INC.ex10-2.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 
FORM 8-K
 

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported)  March 2, 2016
 
BLUE CALYPSO, INC.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation)
 
000-53981
 
20-8610073
(Commission File Number) 
 
(IRS Employer Identification No.)
     
101 W. Renner Rd, Suite 200
Richardson, TX
 
75082
(Address of principal executive offices)
 
(Zip Code)
     
 
(800) 378-2297
(Registrant’s telephone number, including area code)

                                                                                                     
 (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 1.01                      Entry into a Material Definitive Agreement.
 
On March 2, 2016, Blue Calypso, Inc. (the “Company”), pursuant to a Securities Purchase Agreement (the “Purchase Agreement”), issued to certain accredited investors (the “Investors”) 411,765 shares of the Company’s common stock (the “Shares”) and warrants to purchase an additional 102,941 shares of the Company’s common stock (the “Warrants”) for aggregate gross proceeds of $350,000.

The Warrants are exercisable at an exercise price of $1.25 per share for a term of five years. The exercise price and the number of shares issuable upon exercise of the Warrants are subject to adjustment upon the occurrence of certain events, including stock dividends, stock splits, combinations and reclassifications of the Company’s common stock.

The Company paid the placement agent cash commissions equal to $10,000.

Neither the Shares nor the Warrants (including the shares of common stock issuable upon exercise of the Warrants) were registered under the Securities Act of 1933, as amended (the “Securities Act”) at the time of sale, and therefore may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. The securities were issued in a private placement transaction solely to a limited number of accredited investors pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D thereunder, without engaging in any advertising or general solicitation of any kind.

The description of certain terms of the Purchase Agreement and Warrant set forth herein do not purport to be complete and are qualified in its entirety by the provisions of the Purchase Agreement and Warrant, copies of which is attached to this Current Report on Form 8-K as Exhibits 10.1 and 10,2, respectively and are incorporated herein by reference.

Item 3.02                      Unregistered Sales of Equity Securities.
 
The information provided under Item 1.01 regarding the unregistered sale of equity securities is incorporated herein by reference.
 
Item 9.01                      Financial Statements and Exhibits.

(d)           Exhibits
 
 
 
 

 

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  BLUE CALYPSO, INC.  
       
Date:  March 2, 2016       
By:
/s/ Andrew Levi  
    Andrew Levi  
    Chief Executive Officer